Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Short‐acting Beta2‐agonists Versus Ipratropium for Acute Exacerbations of Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434409/2/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed 26 April 2024.
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/2/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_. Accessed April 26, 2024.
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/2/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
Inhaled Short‐acting Beta2‐agonists Versus Ipratropium for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/2/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
ID - 434409
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434409/2/Inhaled_short‐acting_beta2‐agonists_versus_ipratropium_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -